309, 3rd Floor, Gupta Tower, Commercial Complex, Azadpur, Delhi, India - 110033
Mobile : 91-9871127279, +91-9213976876, +91-9999332196
Email ID : firstname.lastname@example.org
Moxonidine (INN) is a new-generation alpha-2/imidazoline receptor agonist antihypertensive drug licensed for the treatment of mild to moderate essential hypertension. It may have a role when thiazides, beta-blockers, ACE inhibitors, and calcium channel blockers are not appropriate or have failed to control blood pressure. In addition, it demonstrates favourable effects on parameters of the insulin resistancesyndrome, apparently independent of blood pressure reduction.